Nippon Shinyaku Co., Ltd.

OTC
NPNKF
Stock
Yield per half year: -52.8%
Dividend yield: 0%
Sector: Healthcare

Nippon Shinyaku Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
21.46 54.24 -60.42% 16.03 +33.88%
P/S 3.4 4.62 -26.5%
P/BV 2.5 4.2 -40.45%
P/FCF 0 16.2 -100%
Ev/Ebitda 12.12 14.71 -17.56%
Ev/S 3 4.05 -25.98%
Ev/FCF 29.95 20.97 42.79%
E/P 0 1.63 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.74 25.2 -1.84% 24.79 -0.2337%
ROE 11.66 12.46 -6.47%
ROA 9.61 6.23 54.14%
ROIC 0 15.34 -100%
ROS 15.82 12.71 24.48%
ROCE 15.63 14.68 6.46%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0749 6.22 -98.8% 0.0779 -3.92%
Nеt Debt/Ebitda -1.61 -3.47 -53.68%
Debt/Ratio 0.0112 0.2246 -94.99%
Debt/Equity 0.2119 1 -78.84%
Debt/Net Income 0.117 18.36 -99.36%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.28 -100% 145.91 -100%
Number of years of dividend growth 0 1.8 -100%
DSI 0.7857 0.8081 -2.78%
Average dividend growth -2159.03 -303.64 611.05%
Average percentage for 5 years 145.91 2.59 5528.5%
Average percentage for payments 29.09 167.32 -82.61%
Difference from average difference in sector -2.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-98.86 -98.5 0.3655%
Growth impulse Ebitda in 5 years -98.7 -98.62 0.0811%
Growth impulse Net Income in 5 years -98.73 -98.32 0.417%
Growth impulse FCF in 5 years -99.05 -98.32 0.7425%
Growth impulse EPS in 5 years -98.73 -82.03 20.36%
IP Score
4.75/10

Similar companies

Eisai Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Astellas Pharma Inc.

Roche Holding

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription